© 2002 The Fellowship of Postgraduate Medicine
CASE REPORT
Possible functional regression of insulinoma with prolonged octreotide
Diabetes Centre, Wycombe General Hospital, High Wycombe, Buckinghamshire HP11 2TT, UK
Correspondence to:
Correspondence to:
Dr Gallen;
iangallen{at}aol.com
A 75 year old woman was treated for over three years with the somatostatin analogue, octreotide for an insulinoma. She had presented in a hypoglycaemic coma. C-peptide and insulin concentrations were both raised and an area of increased vascularity within the pancreas was shown by angiography. No lesion was found at laparotomy and no resection was performed. After over three years of octreotide treatment it was withdrawn for a week. Her insulin and C-peptide concentrations were greatly reduced at this time and remained so.
Keywords: insulinoma; octreotide; somatostatin analogue; hypoglycaemia
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Bryson, E. R., Snead, E. C.R., McMillan, C., MacDougall, L., Allen, A. L.
(2007). Insulinoma in a Dog With Pre-existing Insulin-Dependent Diabetes Mellitus. Journal of the American Animal Hospital Association
43: 65-69
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
